Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
Authors:
- Denise E. RobinsonDRDenise E. Robinson
- 1 February 1998
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 27 (1) , 47-60
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.Endocrinology, 1996
- Effects of Ammonium Perfluorooctanoate on Leydig-Cell Function: In Vitro, in Vivo, and ex Vivo StudiesToxicology and Applied Pharmacology, 1995
- Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced HepatocarcinogenesisHuman & Experimental Toxicology, 1994
- Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localizationCarcinogenesis, 1993
- Hepatic peroxisome proliferation in rodents and its significance for humansFood and Chemical Toxicology, 1993
- Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liverCarcinogenesis, 1993
- PPAR-RXR Heterodimer Activates a Peroxisome Proliferator Response Element Upstream of the Bifunctional Enzyme GeneBiochemical and Biophysical Research Communications, 1993
- Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liverCarcinogenesis, 1991
- Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promotersCarcinogenesis, 1984
- Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patientsAtherosclerosis, 1983